These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24899440)

  • 1. Serum virus neutralization assay for detection and quantitation of serum-neutralizing antibodies to influenza A virus in swine.
    Gauger PC; Vincent AL
    Methods Mol Biol; 2014; 1161():313-24. PubMed ID: 24899440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Virus Neutralization Assay for Detection and Quantitation of Serum Neutralizing Antibodies to Influenza A Virus in Swine.
    Gauger PC; Vincent AL
    Methods Mol Biol; 2020; 2123():321-333. PubMed ID: 32170698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microneutralization assay for swine influenza virus in swine serum.
    Kitikoon P; Vincent AL
    Methods Mol Biol; 2014; 1161():325-35. PubMed ID: 24899441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay.
    He W; Mullarkey CE; Miller MS
    Methods; 2015 Nov; 90():95-100. PubMed ID: 25957674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of influenza A and B neutralizing antibodies in vaccinated ferrets and macaques using specific biotin-streptavidin conjugated antibodies.
    Sirskyj D; Weltzin R; Golshani A; Anderson D; Bozic J; Diaz-Mitoma F; Azizi A
    J Virol Methods; 2010 Feb; 163(2):459-64. PubMed ID: 19913054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.
    Tsukamoto M; Hiroi S; Adachi K; Kato H; Inai M; Konishi I; Tanaka M; Yamamoto R; Sawa M; Handharyani E; Tsukamoto Y
    Mol Med Rep; 2011; 4(2):209-14. PubMed ID: 21468553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a high-throughput Alamar blue assay for the determination of influenza virus infectious dose, serum antivirus neutralization titer and virus ca/ts phenotype.
    Mo C; Yamagata R; Pan A; Reddy J; Hazari N; Duke G
    J Virol Methods; 2008 Jun; 150(1-2):63-9. PubMed ID: 18423899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: a phase I trial in Taiwan.
    Pan SC; Kung HC; Kao TM; Wu H; Dong SX; Hu MH; Chou AH; Chong P; Hsieh SM; Chang SC
    J Microbiol Immunol Infect; 2013 Dec; 46(6):448-55. PubMed ID: 23022464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of GFP-expressing influenza viruses for the detection of influenza virus A/H5N1 neutralizing antibodies.
    Rimmelzwaan GF; Verburgh RJ; Nieuwkoop NJ; Bestebroer TM; Fouchier RA; Osterhaus AD
    Vaccine; 2011 Apr; 29(18):3424-30. PubMed ID: 21396410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cell lines used in a micro neutralization test for measuring influenza-neutralizing antibodies.
    Mittelholzer CM; Brokstad KA; Pauksens K; Jonsson R; Brytting M; Linde A
    Scand J Immunol; 2006 Apr; 63(4):257-63. PubMed ID: 16623925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel, colorimetric neutralization assay for measuring antibodies to influenza viruses.
    Lehtoranta L; Villberg A; Santanen R; Ziegler T
    J Virol Methods; 2009 Aug; 159(2):271-6. PubMed ID: 19406159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemagglutinin inhibition assay with swine sera.
    Kitikoon P; Gauger PC; Vincent AL
    Methods Mol Biol; 2014; 1161():295-301. PubMed ID: 24899438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays.
    Hossain MJ; Perez S; Guo Z; Chen LM; Donis RO
    J Clin Microbiol; 2010 Jul; 48(7):2515-23. PubMed ID: 20504984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Competitive detection of influenza neutralizing antibodies using a novel bivalent fluorescence-based microneutralization assay (BiFMA).
    Baker SF; Nogales A; Santiago FW; Topham DJ; Martínez-Sobrido L
    Vaccine; 2015 Jul; 33(30):3562-70. PubMed ID: 26044496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microneutralization assay in the diagnosis of influenza infection].
    Havlicková M; Jirincová H; Maresová V; Dzupová O; Limberková R
    Epidemiol Mikrobiol Imunol; 2012 May; 61(1-2):9-14. PubMed ID: 22880259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of neutralizing monoclonal antibodies against the pandemic H1N1 virus (2009) using plasmid DNA immunogen.
    Cabral TM; Baig A; Berhane Y; Schmidt L; Hole K; Leith M; Kobasa D; Corbett CR
    J Virol Methods; 2014 Jan; 195():54-62. PubMed ID: 24060631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a neutralization assay for influenza virus using an endpoint assessment based on quantitative reverse-transcription PCR.
    Teferedegne B; Lewis AM; Peden K; Murata H
    PLoS One; 2013; 8(2):e56023. PubMed ID: 23437084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolate.
    Wodal W; Falkner FG; Kerschbaum A; Gaiswinkler C; Fritz R; Kiermayr S; Portsmouth D; Savidis-Dacho H; Coulibaly S; Piskernik C; Hohenadl C; Howard MK; Kistner O; Barrett PN; Kreil TR
    Vaccine; 2012 Jun; 30(31):4625-31. PubMed ID: 22580355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine-induced anti-HA2 antibodies promote virus fusion and enhance influenza virus respiratory disease.
    Khurana S; Loving CL; Manischewitz J; King LR; Gauger PC; Henningson J; Vincent AL; Golding H
    Sci Transl Med; 2013 Aug; 5(200):200ra114. PubMed ID: 23986398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits.
    Zhu H; Ding X; Chen X; Yao P; Xu F; Xie R; Yang Z; Liang W; Zhang Y; Li Y; Shen J; He P; Guo Z; Su B; Sun S; Zhu Z
    Vaccine; 2011 Jul; 29(33):5421-3. PubMed ID: 21645575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.